OWL heads into its August 6 earnings release having surged 23% in a month — yet nearly one in five shares remains sold short.
Short interest is the defining tension in this setup. At 19.7% of free float, the short position is substantial. It has edged up roughly 2% over the past week even as the stock climbed 15% in that same period — a sign that bears are not capitulating despite being squeezed. The borrow market tells a looser story: availability is running at 218%, meaning there is roughly twice as much stock available to lend as is currently borrowed, and cost to borrow remains low at 0.81%. Short sellers can add to positions without difficulty. The options market, meanwhile, shows put/call at 1.24, slightly below its 20-day average of 1.28 — hedging demand is actually a touch lighter than usual for this name, which carries structurally elevated put activity.
Analysts have been revising targets in both directions, but the direction has clearly shifted into the print. Goldman Sachs lifted its target to $10.50 from $9.50 on August 3 while holding a Neutral rating — meaningful for the story because the stock is trading at $11.16, above even the raised target. BMO Capital moved in the same direction, raising to $12.00. The consensus mean sits at $12.44, with Oppenheimer still carrying a $15 target. The bull case centres on Blue Owl's digital infrastructure positioning, its diversified fee-related earnings across publicly and non-publicly traded BDCs, and a forward earnings yield that screens attractively after the year-to-date de-rating. Bears counter with the harder-to-dismiss concern: redemptions in the non-traded BDC complex have exceeded the 5% threshold, management deviated from contractual terms to accommodate them, and the software segment (8% of AUM) faces its own headwinds. That the ORTEX short score has ticked up to 68 from the mid-60s range through July suggests the bear conviction is not fading.
Ownership provides some ballast. Capital Research holds 17.5% of shares, Fidelity (FMR) 11.6%, with Vanguard, ICONIQ, and BlackRock each at roughly 5%. That institutional concentration creates a floor, but it also means a single large holder reducing exposure would be felt. Insider data here is stale — the most recent trades on record date to February 2026 — so no current insider read is available. Worth noting: in December 2025, co-CEOs Ostrover and Lipschultz and President Packer bought a combined $5.8m worth of stock near $15, materially above today's price; those purchases are deeply underwater. The prior print on July 30 saw the stock jump nearly 8% on the day, suggesting recent quarterly results have been received positively — though the stock remains well below pre-print levels from earlier in 2026.
The August 6 release will test whether the rally of the past month reflects genuine fundamental re-rating or a squeeze-driven move that the underlying earnings picture cannot sustain — with almost a fifth of the float still short and borrow conditions loose enough to reload.
See the live data behind this article on ORTEX.
Open OWL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
